North America Antifungal Drugs Market By Drug Type (Echinocandins, Azoles, Polyenes, Allylamines, Other Drugs) By Therapeutic Indications (Aspergillosis, Dermatophytosis, Candidiasis, Other Therapeutic Indications) By Application (Powders, Ointments, Drugs, Pastes), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

North America Antifungal Drugs Market By Drug Type (Echinocandins, Azoles, Polyenes, Allylamines, Other Drugs) By Therapeutic Indications (Aspergillosis, Dermatophytosis, Candidiasis, Other Therapeutic Indications) By Application (Powders, Ointments, Drugs, Pastes), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)

ID: 245 | Pages: 145 | October 2018 | Region: North America


Antifungal drugs are used commonly for curing fungal infections occurring due to, unclean, unhygienic and damp environment. Invasion of epithelial tissue by microscopic organisms lead to fungal infections. Systemic fungal infections are those caused due to indigestion or inhalation of spores, leading to fungal pneumonia and diseases like candidaisis, meningitis, mucormycosis, etc. are caused by opportunistic fungus. Although majority of the fungal infections and diseases are commonly non-lethal, they are very uncomforting to the host and their common occurrence is responsible for the rising antifungal drugs market. Antifungal drugs work via various mechanisms such as by inhibiting of cell wall formation, cell membrane disruption and cell division.

The major factors driving the market are rising awareness of fungal infections with more and more cases of antifungal infections all over the world, increase in government and corporate funding in the industry. Further, the growing public private partnership in the pharmaceutical industry and the mounting popularity of over-the-counter antifungal drugs to cure dermal infections is responsible for the growth of North America antifungal drugs market. Also, the rising population with weak immune system because of cancer chemotherapy or acquired immunodeficiency syndrome, in whom the fungal infections occur more frequently than average, is driving the market in North America. Existing high penetration of conventional drugs used for the treatment of common fungal infections is restraining the market growth. High drug costs are a challenge faced by the market. Increasing treatment effectiveness can help in overcoming it.

North America Antifungal Drugs Market is estimated at $4.97 billion in 2018 and projected to be growing with CAGR of 3.7% reaching $5.96 billion by 2023. In the following years, the market is poised to grow significantly with the rising global population.

The antifungal drugs market is segmented by drug type into Echinocandins, Azoles, Polyenes, Allylamines and Other Drugs. Also, the market is segmented by type of therapeutic indications into Aspergillosis, Dermatophytosis, Candidiasis, Other therapeutic indications. And the market is also segmented by applications into Powders, Ointments, Drugs, Pastes. While Azoles which include fluconazole, itraconazole, ketoconazole, posaconazole and voriconazole, are systemically acting, Echinocandins which include anidulafungin, caspofungin and micafungin are lipopeptides derived from natural fungal fermentation products and Polyenes which include amphotericin B deoxycholate and liposomal amphotericin B. Corifungin are systemically acting and disrupts eukaryotic cellular membranes. Azoles segment is the largest segment of the market followed by echinocandins.

Geographically, the North America antifungal drugs market is sub-segmented into the countries United States and Canada. North America has commanded largest share of the global antifungal drugs market. United States contributes to the major share of North America antifungal drugs market due to the presence of the leading companies. Canada antifungal drugs market is expected to grow fastest in the North America region.

The major companies dominating the market are Alternaria, Pfizer, Novartis, Sanofi-Aventis, Merck & Co., Asperqillus, Kramer Laboratories, Bayer Healthcare, Enzon Pharmaceuticals, Glaxosmithkline Gilead and Abbott Laboratories to name few.

1. Introduction                 

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods          

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction               

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                       

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                    

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market              

5. Market Segmentation                              

                5.1 By Drug Type             

                                5.1.1 Echinocandins

                                5.1.2 Azoles

                                5.1.3 Polyenes

                                5.1.4 Allylamines

                                5.1.5 Others

                5.2 By Therapeutic Indications   

                                5.2.1 Aspergillosis

                                5.2.2 Dermatophytosis

                                5.2.3 Candidiasis

                                5.2.4 Others

                5.3 By Application           

                                5.3.1 Powders

                                5.3.2 Ointments

                                5.3.5 Drugs

                                5.3.4 Pastes

6. Geographical Analysis                              

                                6.1 Introduction

                                6.2 United States

                                6.3 Canada 

7. Strategic Analysis                       

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8. Market Leaders' Analysis                        

                8.1 Alternaria    

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Pfizer            

                8.3 Novartis       

                8.4 Sanofi-Aventis          

                8.5 Merck & Co.               

                8.6 Asperqillus  

                8.7 Kramer Laboratories               

                8.8 Bayer Healthcare     

                8.9 Enzon Pharmaceuticals          

                8.10 Glaxosmithkline Gilead       

                8.11 Abbott Laboratories             

9. Competitive Landscape                           

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis       

                9.3 Agreements, collaborations and Joint Ventures         

                9.4 New Product Launches         

10. Expert Opinions                        

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. North America Antifungal Drugs Market By Region, From 2018-2023(USD Million)
  2. North America Antifungal Drugs Market By Drug Type, From 2018-2023(USD Million)
  3. North America Echinocandins Market By Region, From 2018-2023(USD Million)
  4. North America Azoles Market By Region, From 2018-2023(USD Million)
  5. North America Polyenes Market By Region, From 2018-2023(USD Million)
  6. North America Allylamines Market By Region, From 2018-2023(USD Million)
  7. North America Other Drugs Market By Region, From 2018-2023(USD Million)
  8. North America Antifungal Drugs Market By Therapeutic Indications, From 2018-2023(USD Million)
  9. North America Aspergillosis Market By Region, From 2018-2023(USD Million)
  10. North America Dermatophytosis Market By Region, From 2018-2023(USD Million)
  11. North America Candidiasis Market By Region, From 2018-2023(USD Million)
  12. North America Other Therapeutic Indications Market By Region, From 2018-2023(USD Million)
  13. North America Antifungal Drugs Market By Application, From 2018-2023(USD Million)
  14. North America Powders Market By Region, From 2018-2023(USD Million)
  15. North America Ointments Market By Region, From 2018-2023(USD Million)
  16. North America Drugs Market By Region, From 2018-2023(USD Million)
  17. North America Pastes Market By Region, From 2018-2023(USD Million)
  18. United States Antifungal Drugs Market By Drug Type, From 2018-2023(USD Million)
  19. United States Antifungal Drugs Market By Therapeutic Indications, From 2018-2023(USD Million)
  20. United States Antifungal Drugs Market By Application, From 2018-2023(USD Million)
  21. Canada Antifungal Drugs Market By Drug Type, From 2018-2023(USD Million)
  22. Canada Antifungal Drugs Market By Therapeutic Indications, From 2018-2023(USD Million)
  23. Canada Antifungal Drugs Market By Application, From 2018-2023(USD Million)
Middle East And Africa Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth...
Asia Pacific Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, A...
Europe Angina Pectoris Drugs Market By Therapeutic Class ( Beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Fo...
North America Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, ...
Angina Pectoris Drugs Market By Therapeutic Class (beta Blockers, Calcium Antagonists, Anticoagulants, Anti-platelets And Others) And By Region - Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts ...
Middle East And Africa Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) A...
Latin America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Asia Pacific Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Regi...
Europe Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - I...
North America Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Reg...
Schizophrenia Drugs Agents Market By Therapeutic Class ( Second Generation Anti-psychotics, Third Generation Anti-psychotics And Others) , By Treatment ( Oral And Injectable Anti-psychotics) And By Region - Industry...
Pharmaceutical Gelatin Market By Function (stabilizers, Thickeners, Gelling Agents And Others) , By Source( Pig Skin, Bovine Hides, Bones And Others), By Application ( Hard Capsules, Soft Capsules, Microencapsulatio...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.